Form 8-K PETMED EXPRESS INC For: Jan 17
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): January 17, 2017
PetMed Express, Inc.
| ||||
|
|
|
|
|
Florida |
| 000-28827 |
| 65-0680967 |
(State or other jurisdiction |
| (Commission |
| (I.R.S. Employer |
1441 S.W. 29th Avenue, Pompano Beach, FL 33069 |
(Address of principal executive offices) (Zip Code) |
(954) 979-5995 |
|
(Registrants telephone number, including area code) |
|
Not Applicable |
(Former name or former address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Item 8.01 Other Events.
On January 17, 2017, PetMed Express, Inc. issued a press release stating that it will announce its quarter ending December 31, 2016 financial results and host a conference call to review the results on Monday, January 23, 2017. A copy of this press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
| (d) | Exhibits. |
|
|
|
|
| 99.1 Press release dated January 17, 2017. |
EXHIBIT INDEX
Exhibit No. |
| Description |
|
|
|
|
|
| Press release dated January 17, 2017. |
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: January 18, 2017
| PETMED EXPRESS, INC. | |
|
|
|
| By: | /s/ Bruce S. Rosenbloom |
| Name: | Bruce S. Rosenbloom |
| Title: | Chief Financial Officer |
|
|
|
2
Exhibit 99.1 |
|
PETMED EXPRESS D/B/A 1-800-PETMEDS TO ANNOUNCE ITS THIRD QUARTER FINANCIAL RESULTS ON JANUARY 23, 2017 |
|
Delray Beach, Florida, January 17, 2017 - PetMed Express, Inc. (NASDAQ: PETS) will announce its financial results for the quarter ended December 31, 2016 on Monday, January 23, 2017 at 8:00 A.M. Eastern Time, then at 8:30 A.M. Eastern Time, Menderes Akdag, the Companys Chief Executive Officer and President, will host a conference call to review the financial results. To access the call, which is open to the public, please dial (888) 455-1758 (toll free) or (203) 827-7025, ten minutes prior to the scheduled start time. Callers will be required to supply PETMEDS as the passcode, and will be placed on hold with music until the call begins. For those unable to participate in the live event, the call will be available for replay from 10:00 A.M. on January 23, 2017 until February 6, 2017 at 11:59 P.M. To access the replay, call (888) 568-0521 (toll free) or (402) 998-1495, and enter passcode 5500. Founded in 1996, PetMed Express is Americas Largest Pet Pharmacy, delivering prescription and non-prescription pet medications and other health products for dogs and cats at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and on the Internet through its website at www.1800petmeds.com. This press release may contain forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission, that involve a number of risks and uncertainties, including the Companys ability to meet the objectives included in its business plan. Important factors that could cause results to differ materially from those indicated by such forward-looking statements are set forth in Managements Discussion and Analysis of Financial Condition and Results of Operations in the PetMed Express Annual Report on Form 10-K for the year ended March 31, 2016. The Companys future results may also be impacted by other risk factors listed from time to time in its SEC filings, including, but not limited to, the Company's Form 10-Q and its Annual Report on Form 10-K. For investment relations contact PetMed Express, Inc., Bruce S. Rosenbloom, CFO, 561-526-4444. ### Exhibit 99.1 Page 1 of 1 |
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dr. Anthony Fletcher Installed as President of the Association of Black Cardiologists
- Rush Enterprises, Inc. Reports First Quarter 2024 Results, Announces $0.17 Per Share Dividend
- Catalight Practice Guidelines Reflect a Contemporary Research View of the Dosage Effect and Outcome Measures in Autism Care
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!